This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Nanovation Therapeutics Inc., Nanovision Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dominik Witzigmann: Inventor in Lipid Nanoparticle Technology.
Introduction
Dominik Witzigmann is an inventor associated with Binzen, Germany. His work includes inventions involving lipid nanoparticles and lipid compositions, with applications in DNA delivery and medical treatment. He is credited with 2 patents.
Latest Patents
One of Witzigmann’s latest patent disclosures concerns DNA vector delivery using lipid nanoparticles. It describes nanoparticles that encapsulate a DNA vector and contain 30 to 60 mol % of a neutral lipid selected from sphingomyelin and phosphatidylcholine, alongside at least one sterol or hydrophilic polymer–lipid conjugate. The particles include a core with an electron-dense region and an aqueous portion, partially surrounded by a lipid layer that includes a bilayer.
The disclosure further describes gene expression at a disease site or in the liver, spleen, or bone marrow that is at least 10% higher at a time point after 24 or 48 hours post-injection than expression from a comparator nanoparticle using an Onpattro-type formulation. The comparison is based on measurements of green fluorescent protein or luciferase in an animal model. The patent also addresses medical-treatment methods and uses for these nanoparticles.
Another patent disclosure concerns MC3-type lipids. It describes a lipid structure and methods for making that lipid. The supplied information does not specify the structure itself.
Career Highlights
Witzigmann is associated with Nanovation Therapeutics Inc. and Nanovision Therapeutics Inc. The available information identifies these organizations but does not detail his specific roles or dates of employment.
Collaborations
Anthony C. Y. Tam and Daniel Kurek are identified as Witzigmann’s coworkers. Their connection reflects a professional context around his work, though specific joint projects are not provided.
Conclusion
Dominik Witzigmann’s patent record highlights work on lipid formulations and nanoparticle-based DNA delivery, with potential applications in gene expression and medical treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile